Pinsky PF - Search Results

1

Other and All-Cause Mortality among Men Diagnosed with Prostate Cancer in the PLCO Trial.

Pierre-Victor D, Pinsky PF, Miller E, Parnes H. Pierre-Victor D, et al. Among authors: pinsky pf. J Urol. 2021 May;205(5):1372-1378. doi: 10.1097/JU.0000000000001531. Epub 2020 Dec 22. J Urol. 2021. PMID: 33350321

2

Relationship of demographic and clinical factors to free and total prostate-specific antigen.

Gelmann EP, Chia D, Pinsky PF, Andriole GL, Crawford ED, Reding D, Hayes RB, Kramer BS, Woodrum DL, Gohagan JK, Levin DL; PLCO Screening Trial Investigators. Gelmann EP, et al. Among authors: pinsky pf. Urology. 2001 Oct;58(4):561-6. doi: 10.1016/s0090-4295(01)01305-x. Urology. 2001. PMID: 11597539 Clinical Trial.

3

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.

Pinsky PF, Andriole GL, Kramer BS, Hayes RB, Prorok PC, Gohagan JK; Prostate, Lung, Colorectal and Ovarian Project Team. Pinsky PF, et al. J Urol. 2005 Mar;173(3):746-50; discussion 750-1. doi: 10.1097/01.ju.0000152697.25708.71. J Urol. 2005. PMID: 15711261

4

Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial.

Pinsky PF, Kramer BS, Crawford ED, Grubb RL, Urban DA, Andriole GL, Chia D, Levin DL, Gohagan JK. Pinsky PF, et al. Urology. 2006 Aug;68(2):352-6. doi: 10.1016/j.urology.2006.02.026. Urology. 2006. PMID: 16904451 Clinical Trial.

5

Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.

Pinsky PF, Miller A, Kramer BS, Church T, Reding D, Prorok P, Gelmann E, Schoen RE, Buys S, Hayes RB, Berg CD. Pinsky PF, et al. Am J Epidemiol. 2007 Apr 15;165(8):874-81. doi: 10.1093/aje/kwk075. Epub 2007 Jan 22. Am J Epidemiol. 2007. PMID: 17244633 Clinical Trial.

6

Estimating rates of true high-grade disease in the prostate cancer prevention trial.

Pinsky P, Parnes H, Ford L. Pinsky P, et al. Cancer Prev Res (Phila). 2008 Aug;1(3):182-6. doi: 10.1158/1940-6207.CAPR-07-0007. Epub 2008 May 18. Cancer Prev Res (Phila). 2008. PMID: 19138954 Clinical Trial.

7

Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

Baker SG, Darke AK, Pinsky P, Parnes HL, Kramer BS. Baker SG, et al. Biostatistics. 2010 Jul;11(3):413-8. doi: 10.1093/biostatistics/kxq004. Epub 2010 Feb 19. Biostatistics. 2010. PMID: 20173101 Free PMC article.

8

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Pinsky PF, Blacka A, Kramer BS, Miller A, Prorok PC, Berg C. Pinsky PF, et al. Clin Trials. 2010 Aug;7(4):303-11. doi: 10.1177/1740774510374091. Epub 2010 Jun 22. Clin Trials. 2010. PMID: 20571134

9

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team. Weissfeld JL, et al. Among authors: pinsky pf. J Natl Cancer Inst. 2012 Feb 22;104(4):280-9. doi: 10.1093/jnci/djr549. Epub 2012 Jan 31. J Natl Cancer Inst. 2012. PMID: 22298838 Free PMC article.

10

Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials.

Pinsky PF, Black A, Grubb R, Crawford ED, Andriole G, Thompson I, Parnes H. Pinsky PF, et al. Cancer. 2013 Feb 1;119(3):593-601. doi: 10.1002/cncr.27774. Epub 2012 Aug 14. Cancer. 2013. PMID: 22893105 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters